Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals, including adeno-associated virus (AAV) gene therapies, as well as related consulting activities, project management and regulatory support.
Microbiology Product Areas
Pharmaceutical
Adeno-associated virus (AAV)
Show all suppliersATMP - Advanced Therapeutic Medicinal Products
Show all suppliersCell and Gene Therapies
Show all suppliersContract Research Organization (CRO)
Show all suppliersGene and Cell Therapies
Show all suppliersLATEST MICROBIOLOGY NEWS
-
INTEGRA Acquires Shares in CleanNA
06 Oct 2025 -
AMM/RMM – Pharmacopoeial Developments and More
30 Sep 2025
MICROBIOLOGY EVENTS
-
HACCP Training (Virtual)
14 Oct 2025 -
Advance Your Food Safety Expertise with Internationally Accredited Virtual HACCP Training
14 Oct 2025 -
Test Smarter, Not Harder - Rapid GMO Testing in Agricultural Biotechnology
15 Oct 2025 -
Microbiology Method Evaluation and Verification
16 Oct 2025 -
Responsible AI Development of Alternative Micro Methods Used in Environmental Monitoring
16 Oct 2025 -
Pharma Microbiology Congress: Virtual and In Person, 2025
21 Oct 2025 -
ELRIG Drug Discovery 2025
21 Oct 2025 -
Best Practices in Cleaning and Disinfection - Theory and Practice
21 Oct 2025 -
LIMS Launchpad Webinar Series - Episode #4 – The Vendor Interaction
23 Oct 2025 -
Monitoring the Food Production Environment Using Real-time Total Viable Counts
23 Oct 2025